229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
53.70%
Revenue growth above 1.5x VUZI's 30.70%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
57.49%
Gross profit growth under 50% of VUZI's 1035.89%. Michael Burry would be concerned about a severe competitive disadvantage.
74.11%
EBIT growth above 1.5x VUZI's 39.55%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
74.11%
Operating income growth above 1.5x VUZI's 39.55%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
74.01%
Net income growth at 50-75% of VUZI's 126.54%. Martin Whitman would question fundamental disadvantages in expenses or demand.
73.33%
EPS growth at 50-75% of VUZI's 126.32%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
73.33%
Diluted EPS growth at 50-75% of VUZI's 126.53%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
-0.89%
Share reduction while VUZI is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.84%
Reduced diluted shares while VUZI is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.90%
Dividend growth of 0.90% while VUZI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
128.81%
OCF growth above 1.5x VUZI's 52.02%. David Dodd would confirm a clear edge in underlying cash generation.
171.32%
FCF growth above 1.5x VUZI's 44.41%. David Dodd would verify if the firm’s strategic investments yield superior returns.
2222.64%
Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
462.10%
Positive 5Y CAGR while VUZI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
120.96%
Positive 3Y CAGR while VUZI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
8274.19%
10Y OCF/share CAGR above 1.5x VUZI's 58.79%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
471.22%
5Y OCF/share CAGR above 1.5x VUZI's 58.79%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
137.98%
3Y OCF/share CAGR above 1.5x VUZI's 82.77%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
16685.59%
Net income/share CAGR above 1.5x VUZI's 216.10% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
708.16%
5Y net income/share CAGR above 1.5x VUZI's 216.10%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
123.36%
3Y net income/share CAGR 50-75% of VUZI's 226.78%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
2322.89%
Equity/share CAGR of 2322.89% while VUZI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
461.71%
Equity/share CAGR of 461.71% while VUZI is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
143.38%
3Y equity/share CAGR above 1.5x VUZI's 16.04%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.38%
Our AR growth while VUZI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
20.29%
Inventory growth well above VUZI's 8.60%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
8.78%
Asset growth above 1.5x VUZI's 4.53%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.91%
Under 50% of VUZI's 31.26%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
0.01%
We have some new debt while VUZI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
13.87%
We increase R&D while VUZI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
14.22%
We expand SG&A while VUZI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.
